Impact of Radioimmunoguided Surgery.

Area of Science:

• Surgical Oncology
• Nuclear Medicine
• Colorectal Cancer Research

Background:

• Accurate tumor detection is crucial for effective colorectal cancer treatment.
• Identifying non-palpable tumor deposits remains a challenge in abdominal surgery.
• Current surgical techniques may not always achieve complete tumor resection.

Purpose of the Study:

• To evaluate the utility of Radioimmunoguided Surgery (RIGS) for locating tumor deposits in colorectal cancer.
• To assess the capability of the gamma detecting probe (GDP) in identifying intraoperative tumor sites.
• To determine if RIGS can improve tumor definition, resection extent, and patient survival.

Main Methods:

• RIGS involves intravenous injection of tumor-specific, radiolabeled monoclonal antibodies.
• A portable gamma detecting probe (GDP) is used intraoperatively to scan the peritoneal surface.
• Increased radioactivity detected by the GDP indicates the presence of targeted tumor tissue.

Main Results:

• Human trials demonstrated RIGS's ability to locate clinically non-palpable tumor deposits.
• The system successfully identified increased radioactivity indicative of tumorous tissue during surgery.
• RIGS aided in defining tumor location and extent during abdominal exploration for colorectal cancer.

Conclusions:

• Radioimmunoguided surgery is a valuable tool for detecting occult tumor deposits in colorectal cancer.
• The gamma detecting probe facilitates intraoperative identification of tumorous tissue.
• This technique holds promise for enhancing surgical resection and potentially improving patient outcomes.